Wakix ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

wakix

bioprojet pharma - pitolisant - narcolepsy - druga zdravila na živčnem sistemu - wakix is indicated in adults, adolescents and children from the age of 6 years for the treatment of narcolepsy with or without cataplexy (see also section 5.

Ozawade ইউরোপীয় ইউনিয়ন - স্লোভেনীয় - EMA (European Medicines Agency)

ozawade

bioprojet pharma - pitolisant - sleep apnea, obstructive - druga zdravila na živčnem sistemu - ozawade is indicated to improve wakefulness and reduce excessive daytime sleepiness (eds) in adult patients with obstructive sleep apnoea (osa).